Document is current
Any future updates will be listed below
-
Authors
Katuwal, Nar Bahadur
Kang, Min Sil
Ghosh, Mithun
Hong, Sa Deok
Jeong, Yeong Gyu
Park, Seong Min
Kim, Seul-Gi
Sohn, Joohyuk
Kim, Tae Hoen
Moon, Yong Wha
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF) grants funded by the Korea government (NRF-2021R1C1C1006882, NRF-2021R1A6A3A01086364)
The corresponding author received research funds from several pharmaceutical companies, including ImmunoMet Therapeutics, Hanmi Pharmaceutical Co., and Bixink Therapeutics.
- License Information
-
More Information
Article History
Received: 24 August 2023
Accepted: 14 November 2023
First Online: 28 November 2023
Declarations
:
: All animal procedures were performed according to the approved protocol by the Institutional Animal Care and Use Committee (IACUC) of CHA University (IACUC 190098). The collection of patients’ samples was approved by the Institutional Review Board (IRB) at the CHA Bundang Medical Center (IRB number: 2016–03-037–012).
: The corresponding author received research funds from several pharmaceutical companies, including ImmunoMet Therapeutics, Hanmi Pharmaceutical Co., and Bixink Therapeutics. The authors declare no conflict of interest.
